UPDATE : Monday, September 7, 2020
상단여백
Operating income declines at top 10 biotechs on KOSDAQ
Top 10 biotech companies on the secondary KOSDAQ market posted significant ...
by Nam Doo-hyun  |  2018-11-22 11:15
라인
Celltrion CEO involved in alleged ‘gapjil’ scandal
Celltrion Chairman Seo Jung-jin has reportedly pulled a power trip – ...
by Lee Han-soo  |  2018-11-21 16:02
라인
US data crucial for Korean biosimilars after success in Europe
Korean biosimilar makers will find it more critical to achieve meaningful r...
by Nam Doo-hyun  |  2018-11-21 15:29
라인
FDA OKs sale of Celltrion's HIV biosimilar
Temixys, a generic developed by Celltrion to treat the human immunodeficien...
by Lee Han-soo  |  2018-11-21 12:57
라인
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug
Intron Biotechnology said it has signed a landmark deal for an investigatio...
by So Jae-hyeon  |  2018-11-20 15:00
라인
Celltrion Healthcare presents research results on using biosimilars in Europe
Celltrion Healthcare said Monday that it has presented the financial saving...
by Lee Han-soo  |  2018-11-19 16:57
라인
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US
Bridge Biotherapeutic announced on Monday that the company has filed an inv...
by Lee Han-soo  |  2018-11-19 11:58
라인
Tego Science sales plunge in Q3
Tego Science said Thursday that its sales plunged to 2.1 billion won ($1.8 ...
by Lee Han-soo  |  2018-11-16 14:54
라인
NIBEC wins patent for novel peptide in US
Nano Intelligence Biomedical Engineering Corporation (NIBEC) has acquired a...
by Lee Han-soo  |  2018-11-16 14:40
라인
Samsung BioLogics fiasco hardly affects biotech stocks
The suspension of trading of Samsung BioLogics shares did not have a much n...
by Nam Doo-hyun  |  2018-11-16 11:30
라인
Medipost mark profit losses in Q3
Medipost said Thursday that it recorded an operating loss of 780 million wo...
by Lee Han-soo  |  2018-11-15 15:18
라인
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess
The stock trading suspension of Samsung BioLogics due to the alleged accoun...
by So Jae-hyeon  |  2018-11-15 14:56
라인
Celltrion Healthcare posts ￦212.7 billion in Q3 sales
Celltrion Healthcare, a subsidiary of Celltrion, said Thursday that it reco...
by Lee Han-soo  |  2018-11-15 12:43
라인
Regulators suspend trading of Samsung BioLogics on accounting fraud charges
The Korean Exchange suspended the share trading of Samsung BioLogics on Wed...
by Lee Han-soo  |  2018-11-14 18:28
라인
Alteogen promote antibody-drug conjugate cancer treatment in US
Alteogen said Wednesday that it promoted ALT-P7, an antibody-drug conjugate...
by Lee Han-soo  |  2018-11-14 16:59
라인
GCAM opens new plasma collection centers in US
GCAM, GC’s sister company, said Friday that it has added two additional pla...
by Lee Han-soo  |  2018-11-09 17:58
라인
GC launches Biocon’s antidiabetic biosimilar
GC said Thursday that it has launched Biocon’s Glargia (insulin glargine), ...
by Lee Han-soo  |  2018-11-08 15:46
라인
'Biosimilar makers to benefit from new research accounting guideline'
The Financial Supervisory Service’s recent guidelines for research and deve...
by Nam Doo-hyun  |  2018-11-07 11:23
라인
Biois seeks KOSDAQ listing with ‘technology exception policy’
Biois Corp. said it would utilize the government’s “technology exception po...
by So Jae-hyeon  |  2018-11-06 15:43
라인
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun  |  2018-11-06 15:41
-이전11121314151617-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top